Healthcare Sector Analytics

Market size, company revenue, drug approvals, clinical trials, regulation, hospitals, doctors, drug spending, labs and devices

Brand drug

Imitrex*(Sumatriptan Succinate)GSK plc logoGSK

Medicare prescription drug cost, prescriptions and prescribers, 2024 · made by GSK plc

-

Medicare cost

Medicare drug plans spent on Imitrex* (sumatriptan succinate) in 2024, for prescriptions and refills. It is made by GSK plc (GSK).

Medicare cost

-

Prescriptions

-

- per claim

Patients

-

- prescribers

Total spending, 2024

$5.1M

$6,395.51 per patient

Questions and answers

Who makes Imitrex*?

Imitrex* is made by GSK plc (GSK), listed in the Medicare spending data as Glaxosmithkline.

Spending over the years

Medicare spending by year

All plans and makers

Prescriber data: cost by year

Medicare spending on Imitrex* was $5.1M in 2024, after a high of $6.8M in 2020.

By state

Where the prescribers practice, 2024

Medicare cost by state

States with the highest cost

Makers, 2024

Spending by manufacturer as listed in the spending data

ManufacturerClaimsSpending
GlaxosmithklineGSK logoGSK3,210$5.1M

More drugs: Medicare drug spending and the Prescriptions view.

Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.

LinkedInLinkedInXXYouTubeYouTube